U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07454707) titled 'Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial' on Nov. 27, 2025.
Brief Summary: The overall aim of this research is to improve secondary stroke prevention for older patients with stroke.
In current practice, patients with stroke are often prescribed antiplatelet therapy with either aspirin or clopidogrel to help prevent recurrent strokes. However, an antiplatelet medication may not be effective enough for some patients.
A promising new treatment strategy to enhance stroke prevention involves a very low dose of an anticoagulant (anti-clotting medication) added to the s...